Zusammenfassung
Oxytocin-Dimer (α + β), ein Nebenprodukt der Oxytocin-Synthese, zeigt in 6 Versuchsanordnungen schwache, aber messbare neurohypophysäre Aktivitäten.
Literatur
R. A. Boissonnas, St. Guttmann, P.-A. Jaquenod andJ.-P. Waller, Helv. chim. Acta38, 1491 (1955).
V. du Vigneaud, Ch. Ressler, J. M. Swan, C. W. Roberts, P. C. Katsoyannis andS. Gordon, J. Am. chem. Soc.25, 4879 (1953).
D. Yamashiro, D. B. Hope andV. du Vigneaud, J. Am. chem. Soc.90, 3857 (1968).
H. L. Aaning andD. Yamashiro, J. Am. chem. Soc.92, 5214 (1970).
O. H. Lowry, N. J. Rosebrough, A. L. Farr andR. J. Randall, J. biol. Chem.193, 265 (1951).
B. Berde andR. A. Boissonnas, inHandbook of Experimental Pharmacology (Ed.B. Berde; Springer-Verlag, Berlin, Heidelberg, New York 1968), vol. 23, p. 802.
P. Holton, Br. J. Pharmac.3, 328 (1948).
B. Berde, W. Doepfner andH. Konzett, Br. J. Pharmac.12, 209 (1957).
B. Berde andA. Cerletti, Acta endocr., Copenh.34, 543 (1960).
Pharmacopeia of the United States of America, XIV. Revision, Easton 1950.
British Pharmacopeia (Pharmaceutical Press, London 1968).
B. Berde andA. Cerletti, Helv. physiol. Acta19, 135 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berde, B., Jaquenoud, P.A. & Stürmer, E. Some pharmacological properties of oxytocin-dimers (α + β). Experientia 27, 1304–1305 (1971). https://doi.org/10.1007/BF02136703
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02136703